Increasing evidence has revealed that mast cell–derived tumor necrosis factor α (TNF-α) plays a critical role in a number of inflammatory responses by recruiting inflammatory leukocytes. In this paper, we investigated the regulatory role of interleukin 4 (IL-4) in TNF-α production in mast cells. IL-4 inhibited immunoglobulin E–induced TNF-α production and neutrophil recruitment in the peritoneal cavity in wild-type mice but not in signal transducers and activators of transcription 6 (Stat6)–deficient mice. IL-4 also inhibited TNF-α production in cultured mast cells by a Stat6-dependent mechanism. IL-4–Stat6 signaling induced TNF-α mRNA destabilization in an AU-rich element (ARE)–dependent manner, but did not affect TNF-α promoter activity. Furthermore, IL-4 induced the expression of tristetraprolin (TTP), an RNA-binding protein that promotes decay of ARE-containing mRNA, in mast cells by a Stat6-dependent mechanism, and the depletion of TTP expression by RNA interference prevented IL-4–induced down-regulation of TNF-α production in mast cells. These results suggest that IL-4–Stat6 signaling induces TTP expression and, thus, destabilizes TNF-α mRNA in an ARE-dependent manner.
Skip Nav Destination
Article navigation
1 December 2003
Article|
November 24 2003
IL-4–Stat6 Signaling Induces Tristetraprolin Expression and Inhibits TNF-α Production in Mast Cells
Kotaro Suzuki,
Kotaro Suzuki
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Hiroshi Nakajima,
Hiroshi Nakajima
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Kei Ikeda,
Kei Ikeda
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Yuko Maezawa,
Yuko Maezawa
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Akira Suto,
Akira Suto
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Hiroaki Takatori,
Hiroaki Takatori
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Yasushi Saito,
Yasushi Saito
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Itsuo Iwamoto
Itsuo Iwamoto
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Search for other works by this author on:
Kotaro Suzuki
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Hiroshi Nakajima
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Kei Ikeda
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Yuko Maezawa
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Akira Suto
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Hiroaki Takatori
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Yasushi Saito
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Itsuo Iwamoto
Department of Internal Medicine II, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan
Address correspondence to Hiroshi Nakajima, Dept. of Internal Medicine II, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba City, Chiba 260-8670, Japan. Phone: 81-43-226-2093; Fax: 81-43-226-2095; email: [email protected]
Abbreviations used in this paper: ARE, AU-rich element; DOX, doxycycline; GFP, green fluorescent protein; HSA, human serum albumin; MAP, mitogen-activated protein; RNAi, RNA interference; shRNA, short hairpin RNA; Stat6, signal transducers and activators of transcription 6; TTP, tristetraprolin.
Received:
October 02 2003
Accepted:
October 17 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2003
J Exp Med (2003) 198 (11): 1717–1727.
Article history
Received:
October 02 2003
Accepted:
October 17 2003
Citation
Kotaro Suzuki, Hiroshi Nakajima, Kei Ikeda, Yuko Maezawa, Akira Suto, Hiroaki Takatori, Yasushi Saito, Itsuo Iwamoto; IL-4–Stat6 Signaling Induces Tristetraprolin Expression and Inhibits TNF-α Production in Mast Cells . J Exp Med 1 December 2003; 198 (11): 1717–1727. doi: https://doi.org/10.1084/jem.20031701
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement